Hedge funds are managed by some of the most brilliant investing minds in the world, who employ teams of analysts and powerful algorithms to determine the best stocks to buy for their clients. The following three pharma stocks are the ones they have bought the most as of June 30 according to data compiled by InsiderMonkey.com.
- Johnson & Johnson (JNJ) – Thanks to a robust late-stage pipeline, 66 hedge funds tracked by Insider Monkey owned Johnson & Johnson, making it the most popular pharma stock.
- Thermo Fisher (TMO) – Thermo Fisher provides comprehensive drug pipeline support to pharmaceutical companies and ranks tied for second with 59 hedge fund shareholders.
- Merck (MRK) – Also with 59 hedge fund owners is Merck, which is developing numerous cancer treatments, in addition to drugs that aim to combat HIV, Ebola, schizophrenia, and other conditions.